Home Newsfeeds Mizuho Downgrades Avista to Underperform, Lowers Price Target to $38

Mizuho Downgrades Avista to Underperform, Lowers Price Target to $38

Mizuho analyst Anthony Crowdell downgrades Avista (NYSE:AVA) from Neutral to Underperform and lowers the price target from $45 to $38.

byBenzinga Newsdesk

February 9, 2023

1 minute read

Mizuho analyst Anthony Crowdell downgrades Avista (NYSE:AVA) from Neutral to Underperform and lowers the price target from $45 to $38.

Investor Optimism Improves Ahead of Apple, Amazon Earnings

By Lisa Levin

August 3, 3:14 AM

The CNN Money Fear and Greed index showed some improvement in overall sentiment among U.S. investors on Wednesday. U.S. stocks closed lower on Wednesday, with the Nasdaq Composite recording its worst session since February, after Fitch downgraded the long-term credit rating of the U.S.

AAPL

Reported Late Wednesday, Iveric Bio Announces Pricing Of $300M Public Offering Of 13,350,000 Shares Of Common Stock At A Price Of $22.50/Share

By Benzinga Newsdesk

December 1, 2:12 AM

IVERIC bio, Inc. (NASDAQ:ISEE) (the "Company"), today announced the pricing of an upsized underwritten public offering of 13,350,000 shares of its common stock at a price to the public of $22.50 per share, less underwriting discounts and commissions.

ISEE